![](/img/cover-not-exists.png)
MA21.05 Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer
Watanabe, S., Matsumoto, N., Koshio, J., Ishida, A., Tanaka, T., Abe, T., Ishikawa, D., Shoji, S., Nozaki, K., Ichikawa, K., Kondo, R., Otsubo, A., Aoki, A., Kajiwara, T., Koyama, K., Miura, S., YoshiVolume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.676
Date:
October, 2019
File:
PDF, 118 KB
2019